Exits
Zurmont Madison sells CLS for $77m
Exit comes after five-year holding period
Nordic Capital's Thule Group sets IPO price range
IPO will see a 30% free float of the group, valued at a maximum of SEK 2.22bn
Nordic floating frenzy flounders
Despite recent developments, 2014 will be a stand out year for Nordic listings
Patron partially exits Generator
Patron has sold a 23% stake in Generator for €60m
Capricorn et al. raise €15m in Nexstim float
Company has received тЌ25.1m in capital since 2007
Enterprise Investors lists Skarbiec
IPO generates proceeds of €10.2m
Warburg's Clondalkin sells specialist packaging division for $455m
Acquisition reportedly largest ever made by Essentra
FSN Capital mulls Troax listing
Carnegie and Handelsbanken appointed as financial advisers
Altor sells Apotek Hjärtat for SEK 5.7bn
GP chose trade sale instead of IPO amid OW Bunker crisis
HPE acquires 13% stake in Kreditech
Värde led $40m series-B round for the company in June
Kion to list further 8 million shares
KKR and Goldman Sachs divest further stake in 2007-vintage portfolio company
Reputation issues linger despite value creation
"The industry does have a reputation issue," says Endless's Garry Wilson
Inflexion divests Griffin Global Group
PE fund is understood to have reaped 2.8x money on 2009 investment
Encore picks up 37 Degrees from Albion
Deal follows Encore's acquisition of The Third Space
NPM sells Seafox
Firm has retained a minority stake in Seafox's new enlarged group
LDC's Fever Tree raises £93m in IPO
LDC has retained a 10.4% stake in the now listed company
Waterland sells Omega for €3.6bn
Deal values Omega's equity at €2.48bn
Core Capital sells Kelway
US corporate CDW takes 35% stake
Rhône Capital sells S&B for €525m
Rhône sells its entire 39% stake for cash
Bencis sells Desso to KKR's Tarkett for €160m
Enterprise value represents 7x Desso's expected 2014 EBITDA
Molecular Partners to raise CHF 96m after IPO delay
Offering will give company a market cap of CHF 485m
Sunstone et al. sell Galecto for $444m
Bristol-Myers Squibb signs option to buy company within 60 days of successful clinical trials
Wellington et al. divest Definiens in $150m trade sale
Gilde Healthcare, TVM Capital and Cipio Partners also exit company
Venture-backed F-Star acquired by Bristol-Myers Squibb
Bristol has acquired Viennese company F-Star Alpha for up to $475m